Phase II study of neoadjuvant 5-FU [fluorouracil] + leucovorin [folinic acid] + CPT-11 [irinotecan] in patients with resectable liver metastases from colorectal adenocarcinoma.

Trial Profile

Phase II study of neoadjuvant 5-FU [fluorouracil] + leucovorin [folinic acid] + CPT-11 [irinotecan] in patients with resectable liver metastases from colorectal adenocarcinoma.

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Jul 2015

At a glance

  • Drugs Fluorouracil (Primary) ; Folinic acid (Primary) ; Irinotecan (Primary)
  • Indications Cancer metastases; Colorectal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Jan 2012 Actual end date (May 2009) added as reported by ClinicalTrials.gov.
    • 18 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 20 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top